Dr Reddy’s gets DGCI clearance for Zytorvi; Here’s how company shares reacted

Dr Reddy’s Laboratories received DCGI approval for Zytorvi to treat advanced oesophageal squamous cell carcinoma in India.

Leave a Reply

Your email address will not be published. Required fields are marked *